Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Clinical Microbiology
|
October 16, 2001
Tuberculosis transmission in Botswana
S Bonora, M Boffito, S Audagnotto, et al.
The New Microbiologica
|
January 14, 2005
Clinical pharmacology of antiretroviral therapy
G Di Perri, A Sinicco, S Audagnotto, et al.
Infection
|
June 15, 2007
Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients
F G De Rosa, S Cicalini, F Canta, et al.
The Journal of Antimicrobial Chemotherapy
|
June 25, 2010
Is peritoneal fluid a sanctuary site for HIV?
A Calcagno, R Rostagno, S Audagnotto, et al.
Journal of Biological Regulators and Homeostatic Agents
|
May 11, 2002
Successful simplification of HAART in patients with acute primary HIV infection
A Sinicco, S Bonora, I Arnaudo, et al.
The Journal of Antimicrobial Chemotherapy
|
March 25, 2006
Penetration of didanosine in semen of HIV-1-infected men
M Cruciani, G Liuzzi, A Chirianni, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 2, 2003
Is a 3-month course of treatment with Peg-interferon effective in acute HCV hepatitis?
G Cariti, S Quaglia, I Meoli, et al.
Journal of Neurovirology
|
August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
A Calcagno, C Atzori, A Romito, et al.
Journal of Neurovirology
|
June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART era
A Calcagno, M C Alberione, A Romito, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 10, 2016
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
A Calcagno, A Romito, C Atzori, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Clinical Microbiology
|
October 16, 2001
Tuberculosis transmission in Botswana
S Bonora, M Boffito, S Audagnotto, et al.
The New Microbiologica
|
January 14, 2005
Clinical pharmacology of antiretroviral therapy
G Di Perri, A Sinicco, S Audagnotto, et al.
Infection
|
June 15, 2007
Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients
F G De Rosa, S Cicalini, F Canta, et al.
The Journal of Antimicrobial Chemotherapy
|
June 25, 2010
Is peritoneal fluid a sanctuary site for HIV?
A Calcagno, R Rostagno, S Audagnotto, et al.
Journal of Biological Regulators and Homeostatic Agents
|
May 11, 2002
Successful simplification of HAART in patients with acute primary HIV infection
A Sinicco, S Bonora, I Arnaudo, et al.
The Journal of Antimicrobial Chemotherapy
|
March 25, 2006
Penetration of didanosine in semen of HIV-1-infected men
M Cruciani, G Liuzzi, A Chirianni, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 2, 2003
Is a 3-month course of treatment with Peg-interferon effective in acute HCV hepatitis?
G Cariti, S Quaglia, I Meoli, et al.
Journal of Neurovirology
|
August 7, 2015
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients
A Calcagno, C Atzori, A Romito, et al.
Journal of Neurovirology
|
June 29, 2014
Prevalence and predictors of blood-brain barrier damage in the HAART era
A Calcagno, M C Alberione, A Romito, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 10, 2016
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis
A Calcagno, A Romito, C Atzori, et al.
Page
of 2